Clinical Trial Update: A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of SHR-2004 Injection for prevention of venous thromboembolism in total knee arthroplasty patients has completed. The sponsor is Beijing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thrombosis
• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• SHR-2004 Injection (SHR-2004)

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Prevention of Arterial and Venous Thrombosis | Phase 3 | Status: COMPLETED